Medical Information Market Size, Share & Trends Report

Medical Information Market Size, Share & Trends Analysis Report By Service Provider (In House, Outsourcing), By Therapeutic Area, By Product Life Cycle, By Company Size, By End-use, By Region, And Segment Forecasts, 2020 - 2027

  • Report ID: GVR-4-68039-122-8
  • Number of Pages: 180
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2018
  • Industry: Healthcare

Table of Contents

Chapter 1 Research Methodology & Scope
                   1.1 Market Segmentation & Scope
                       1.1.1 Service Provider
                       1.1.2 TherapeutiC area
                       1.1.3 Company Size
                       1.1.4 Product Life Cycle
                       1.1.5 Category
                       1.1.6 Regional Scope
                       1.1.7 Estimates and Forecast Timeline
                   1.2 Market Definitions
                       1.2.1 Medical Information
                   1.3 Research Methodology
                   1.4 Information Procurement
                       1.4.1 Purchased database:
                       1.4.2 GVR’s Internal Database
                       1.4.3 Secondary sources
                       1.4.4 Primary Research:
                       1.4.5 Details of Primary Research
                           1.4.5.1 Data for primary interviews
                   1.5 Information or Data Analysis
                       1.5.1 Data Analysis Models
                   1.6 Market Formulation & Validation
                   1.7 Model Details
                       1.7.1 Commodity Flow Analysis (Model 1)
                   1.8 List of Secondary Sources
                   1.9 Report Objectives
                       1.9.1 Objective 1:
                       1.9.2 Objective 2:
Chapter 2 Executive Summary
                   2.1 Market Outlook
Chapter 3 Medical Information Market Variables, Trends & Scope
                   3.1 Medical Information Market Dynamics
                       3.1.1 Market driver analysis
                           3.1.1.1 strategic initiatives by market players
                           3.1.1.2 increasing Adoption of artificial intelligence followed by growing demand for healthcare information systems in the healthcare organizations
                           3.1.1.3 outsourcing of medical information services
                       3.1.2 Market restraint analysis
                           3.1.2.1 data security and privacy concerns
                           3.1.2.2 issues with interoperability and high cost of integration
                   3.2 Regulatory Framework
                       3.2.1 Standard & Compliance
                   3.3 Medical information Market Analysis Tools: Porters
                       3.3.1 Bargaining Power of Suppliers
                       3.3.2 Bargaining Power of Buyers
                       3.3.3 Threat of Substitutes
                       3.3.4 Threat of New Entrants
                       3.3.5 Industry Rivalry
                   3.4 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
                       3.4.1 Political & Legal
                       3.4.2 Economic
                       3.4.3 Technological & Social
Chapter 4 Pricing Analysis
                   4.1 Organization Structure Introduction
                   4.2 Pricing Models
                       4.2.1 MedicAL Affairs Budget allocation by activities
                       4.2.2 Pricing Level
                           4.2.2.1 Medical writing
Chapter 5 Emerging Trends in Medical Information Market
                   5.1 Artificial Intelligence, Machine Learning/Automation
                   5.2 Big Data and Analytics
                   5.3 Speech & Video Analytics
                   5.4 IoT
                   5.5 Cloud
                   5.6 Blockchain
Chapter 6 Medical Information Market: Competitive Analysis
                   6.1 Innovators
                   6.2 Public Companies
                       6.2.1 Company market share analysis
                       6.2.2 Vendor Landscape
                   6.3 Major Deals & Acquisitions
Chapter 7 Medical Information Market: Service Provider Estimates & Trend Analysis
                   7.1 Service Provider Market Share Analysis, 2019 & 2027
                   7.2 Service Provider Dashboard
                       7.2.1 In House
                           7.2.1.1 In house market estimates and forecasts, 2016 - 2027 (USD Million)
                       7.2.2 Contract Outsourcing
                           7.2.2.1 Contract outsourcing market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 8 Medical Information Market: Therapeutic Area Estimates & Trend Analysis
                   8.1 Therapeutic Area Market Share Analysis, 2019 & 2027
                   8.2 Therapeutic Area Dashboard
                       8.2.1 Oncology
                           8.2.1.1 Oncology market estimates and forecasts, 2016 - 2027 (USD Million)
                       8.2.2 Neurology
                           8.2.2.1 Neurology market estimates and forecasts, 2016 - 2027 (USD Million)
                       8.2.3 Cardiology
                           8.2.3.1 Cardiology market estimates and forecasts, 2016 - 2027 (USD Million)
                       8.2.4 Immunology
                           8.2.4.1 Immunology market estimates and forecasts, 2016 - 2027 (USD Million)
                       8.2.5 Others
                           8.2.5.1 Others market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 9 Medical Information Market: Company size Estimates & Trend Analysis
                   9.1 Company Size Market Share Analysis, 2019 & 2027
                   9.2 Company Size Dashboard
                       9.2.1 Small
                           9.2.1.1 Small market estimates and forecasts, 2016 - 2027 (USD Million)
                       9.2.2 Medium
                           9.2.2.1 Medium market estimates and forecasts, 2016 - 2027 (USD Million)
                       9.2.3 Large Scale
                           9.2.3.1 Large Scalemarket estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 10 Medical information Market: Product Life Cycle Estimates & Trend Analysis
                   10.1 Product Life Cycle Market Share Analysis, 2019 & 2027
                   10.2 Product Life Cycle Dashboard
                       10.2.1 Preclinical
                           10.2.1.1 Preclinical market estimates and forecasts, 2016 - 2027 (USD Million)
                       10.2.2 Clinical
                           10.2.2.1 Clinical market estimates and forecasts, 2016 - 2027 (USD Million)
                       10.2.3 Post Market Approval
                           10.2.3.1 PMA market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 11 Medical Information Market: Category Estimates & Trend Analysis
                   11.1 Category Market Share Analysis, 2019 & 2027
                   11.2 Category Dashboard
                       11.2.1 Pharmaceuticals
                           11.2.1.1 Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
                           11.2.1.2 Innovators
                               11.2.1.2.1 Innovators market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.1.2.2 Pre-clinical
                                   11.2.1.2.2.1 Pre-clinical market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.1.2.3 Clinical
                                   11.2.1.2.3.1 Clinical market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.1.2.4 PMA
                                   11.2.1.2.4.1 PMA market estimates and forecasts, 2016 - 2027 (USD Million)
                           11.2.1.3 Generics
                               11.2.1.3.1 Generics market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.1.3.2 Pre-clinical
                                   11.2.1.3.2.1 Pre-clinical market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.1.3.3 Clinical
                                   11.2.1.3.3.1 Clinical market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.1.3.4 PMA
                                   11.2.1.3.4.1 PMA market estimates and forecasts, 2016 - 2027 (USD Million)
                       11.2.2 Biotechnology companies
                           11.2.2.1 Biotechnology companies market estimates and forecasts, 2016 - 2027 (USD Million)
                           11.2.2.2 Biologics
                               11.2.2.2.1 Biologics market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.2.2.2 Pre-clinical
                                   11.2.2.2.2.1 Pre-clinical market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.2.2.3 Clinical
                                   11.2.2.2.3.1 Clinical market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.2.2.4 PMA
                                   11.2.2.2.4.1 PMA market estimates and forecasts, 2016 - 2027 (USD Million)
                           11.2.2.3 ATMPs
                               11.2.2.3.1 ATMPs market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.2.3.2 Pre-clinical
                                   11.2.2.3.2.1 Pre-clinical market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.2.3.3 Clinical
                                   11.2.2.3.3.1 Clinical market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.2.3.4 PMA
                                   11.2.2.3.4.1 PMA market estimates and forecasts, 2016 - 2027 (USD Million)
                           11.2.2.4 Biosimilar
                               11.2.2.4.1 Biosimilar market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.2.4.2 Pre-clinical
                                   11.2.2.4.2.1 Pre-clinical market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.2.4.3 Clinical
                                   11.2.2.4.3.1 Clinical market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.2.4.4 PMA
                                   11.2.2.4.4.1 PMA market estimates and forecasts, 2016 - 2027 (USD Million)
                       11.2.3 Medical device manufacturers
                           11.2.3.1 Medical device manufacturers market estimates and forecasts, 2016 - 2027 (USD Million)
                           11.2.3.2 Therapeutic medical devices
                               11.2.3.2.1 Therapeutic medical devices market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.3.2.2 Pre-clinical
                                   11.2.3.2.2.1 Pre-clinical market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.3.2.3 Clinical
                                   11.2.3.2.3.1 Clinical market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.3.2.4 PMA
                                   11.2.3.2.4.1 PMA market estimates and forecasts, 2016 - 2027 (USD Million)
                           11.2.3.3 Diagnostic medical devices
                               11.2.3.3.1 Diagnostic medical devices market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.3.3.2 Pre-clinical
                                   11.2.3.3.2.1 Pre-clinical market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.3.3.3 Clinical
                                   11.2.3.3.3.1 Clinical market estimates and forecasts, 2016 - 2027 (USD Million)
                               11.2.3.3.4 PMA
                                   11.2.3.3.4.1 PMA market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 12 Medical Information Market: Regional Estimates & Trend Analysis by Segments
                   12.1 Regional Market Snapshot
                   12.2 Market Share Analysis by Country, 2019
                       12.2.1 North America
                       12.2.2 Europe
                       12.2.3 Asia Pacific
                       12.2.4 Latin America
                       12.2.5 MEA
                   12.3 North America
                       12.3.1 North America Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
                       12.3.2 The U.S.
                           12.3.2.1 The U.S. Medical information market estimates and forecasts, 2014 - 2026 ( USD Million)
                       12.3.3 Canada
                           12.3.3.1 Canada Medical information market estimates and forecasts, 2014 - 2026 (USD Million)
                   12.4 Europe
                       12.4.1 Europe Medical information MARKET estimates and forecasts, 2016 - 2027 (USD Million)
                       12.4.2 The U.K.
                           12.4.2.1 The U.K. Medical information market estimates and forecasts, 2014 - 2026 (USD Million)
                       12.4.3 Germany
                           12.4.3.1 Germany Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
                       12.4.4 France
                           12.4.4.1 France Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
                       12.4.5 Italy
                           12.4.5.1 Italy Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
                       12.4.6 Spain
                           12.4.6.1 Spain medical information market estimates and forecasts, 2016 - 2027 (USD Million)
                   12.5 Asia Pacific
                       12.5.1 Asia Pacific Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
                       12.5.2 Japan
                           12.5.2.1 Japan Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
                       12.5.3 China
                           12.5.3.1 China Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
                       12.5.4 India
                           12.5.4.1 India Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
                   12.6 Latin America
                       12.6.1 Latin America Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
                       12.6.2 Brazil
                           12.6.2.1 Brazil Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
                       12.6.3 Mexico
                           12.6.3.1 Mexico Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
                   12.7 MEA
                       12.7.1 MEA Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
                       12.7.2 South Africa
                           12.7.2.1 South Africa Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
                       12.7.3 Saudi Arabia
                           12.7.3.1 Saudi Arabia Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 13 Company Profiles
                   13.1 McKesson Corporation
                       13.1.1 Company overview
                       13.1.2 Financial performance
                       13.1.3 R&D expenditure
                       13.1.4 Geographic foothold
                       13.1.5 Organization structure & Team Composition
                           13.1.5.1 Team composition
                       13.1.6 Platform benchmarking
                       13.1.7 Strategic initiatives
                       13.1.8 SWOT Analysis
                   13.2 Parexel International Corporation
                       13.2.1 Company overview
                       13.2.2 Financial performance
                       13.2.3 Organization structure & Team Composition
                           13.2.3.1 Team composition
                       13.2.4 Platform benchmarking
                       13.2.5 Strategic initiatives
                       13.2.6 SWOT Analysis
                   13.3 IQVIA
                       13.3.1 Company overview
                       13.3.2 Financial performance
                       13.3.3 Geographic foothold
                       13.3.4 Organization structure & Team Composition
                           13.3.4.1 Team composition
                       13.3.5 Platform benchmarking
                       13.3.6 Strategic initiatives
                       13.3.7 SWOT Analysis
                   13.4 C3i Solutions, HCL Technologies Company
                       13.4.1 Company overview
                       13.4.2 Financial performance
                       13.4.3 R&D expenditure
                       13.4.4 Geographic foothold
                       13.4.5 Organization structure & Team Composition
                           13.4.5.1 Team composition
                       13.4.6 Platform benchmarking
                       13.4.7 Strategic initiatives
                       13.4.8 SWOT Analysis
                   13.5 PrimeVigilance
                       13.5.1 Company overview
                       13.5.2 Financial performance
                       13.5.3 R&D expenditure
                       13.5.4 Geographic foothold
                       13.5.5 Organization structure & Team Composition
                           13.5.5.1 Team composition
                       13.5.6 Platform benchmarking
                       13.5.7 Strategic initiatives
                       13.5.8 SWOT Analysis
                   13.6 ProPharma Group
                       13.6.1 Company overview
                       13.6.2 Financial performance
                       13.6.3 Organization structure & Team Composition
                           13.6.3.1 Team composition
                       13.6.4 Platform benchmarking
                       13.6.5 Strategic initiatives
                       13.6.6 SWOT Analysis
                   13.7 Accenture
                       13.7.1 Company overview
                       13.7.2 Financial performance
                       13.7.3 R&D expenditure
                       13.7.4 Geographic foothold
                       13.7.5 Organization structure & Team Composition
                           13.7.5.1 Team composition
                       13.7.6 Platform benchmarking
                       13.7.7 Strategic initiatives
                       13.7.8 SwOT Analysis
                   13.8 Cognizant
                       13.8.1 Company overview
                       13.8.2 Financial performance
                       13.8.3 Geographic foothold
                       13.8.4 Organization structure & Team Composition
                           13.8.4.1 Team composition
                       13.8.5 Platform benchmarking
                       13.8.6 Strategic initiatives
                       13.8.7 SWOT Analysis
                   13.9 Infosys Limited
                       13.9.1 Company overview
                       13.9.2 Financial performance
                       13.9.3 R&D expenditure
                       13.9.4 Geographic foothold
                       13.9.5 Organization structure & Team Composition
                           13.9.5.1 Team composition
                       13.9.6 Platform benchmarking
                       13.9.7 Strategic initiatives
                       13.9.8 SWOT Analysis
                   13.10 PharmCentre
                       13.10.1 Company overview
                       13.10.2 Financial performance
                       13.10.3 Organization structure & Team Composition
                           13.10.3.1 Team composition
                       13.10.4 Platform benchmarking
                       13.10.5 Strategic initiatives
                       13.10.6 SWOT Analysis
Chapter 14 Winning Strategies
                   14.1 Key Winning/Scoring Criteria
                       14.1.1 By categories
                           14.1.1.1 Pharmaceuticals
                           14.1.1.2 Biotechnology companies
                           14.1.1.3 Medical device companies
                   14.2 Key Vendor Selection Factors
                       14.2.1 By Category
                       14.2.2 BY Company size
                           14.2.2.1 by geographies
Chapter 15 Switching Cost Analysis
Chapter 16 Covid-19 Impact Analysis
                   16.1 Current And Future Impact Analysis
                   16.2 Covid-19 Opportunity Analysis


List of Tables

TABLE 1 List of secondary sources
TABLE 2 Key leading market players anticipated to witness highest growth
TABLE 3 List of companies
TABLE 4 North America medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 5 North America medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 6 North America medical information market by company size, 2016 - 2027 (USD Million)
TABLE 7 North America medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 8 North America medical information market by end use, 2016 - 2027 (USD Million)
TABLE 9 North America pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 10 North America innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 11 North America generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 12 North America biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 13 North America biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 14 North America ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 15 North America biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 16 North America medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 17 North America diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 18 North America therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 19 The U.S. medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 20 The U.S. medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 21 The U.S. medical information market by company size, 2016 - 2027 (USD Million)
TABLE 22 The U.S. medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 23 The U.S. medical information market by end use, 2016 - 2027 (USD Million)
TABLE 24 The U.S. pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 25 The U.S. innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 26 The U.S. generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 27 The U.S. biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 28 The U.S. biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 29 The U.S. ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 30 The U.S. biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 31 The U.S. medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 32 The U.S. diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 33 The U.S. therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 34 Canada medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 35 Canada medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 36 Canada medical information market by company size, 2016 - 2027 (USD Million)
TABLE 37 Canada medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 38 Canada medical information market by end use, 2016 - 2027 (USD Million)
TABLE 39 Canada pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 40 Canada innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 41 Canada generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 42 Canada biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 43 Canada biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 44 Canada ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 45 Canada biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 46 Canada medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 47 Canada diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 48 Canada therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 49 Europe medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 50 Europe medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 51 Europe medical information market by company size, 2016 - 2027 (USD Million)
TABLE 52 Europe. medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 53 Europe medical information market by end use, 2016 - 2027 (USD Million)
TABLE 54 Europe pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 55 Europe innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 56 Europe generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 57 Europe biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 58 Europe biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 59 Europe ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 60 Europe biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 61 Europe medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 62 Europe diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 63 Europe therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 64 The U.K. medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 65 The U.K. medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 66 The U.K. medical information market by company size, 2016 - 2027 (USD Million)
TABLE 67 The U.K. medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 68 The U.K. medical information market by end use, 2016 - 2027 (USD Million)
TABLE 69 The U.K. pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 70 The U.K. innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 71 The U.K. generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 72 The U.K. biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 73 The U.K. biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 74 The U.K. ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 75 The U.K. biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 76 The U.K. medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 77 The U.K. diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 78 The U.K. therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 79 Germany medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 80 Germany medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 81 Germany medical information market by company size, 2016 - 2027 (USD Million)
TABLE 82 Germany medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 83 Germany medical information market by end use, 2016 - 2027 (USD Million)
TABLE 84 Germany pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 85 Germany innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 86 Germany generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 87 Germany biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 88 Germany biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 89 Germany ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 90 Germany biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 91 Germany medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 92 Germany diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 93 Germany therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 94 France medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 95 France medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 96 France medical information market by company size, 2016 - 2027 (USD Million)
TABLE 97 France medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 98 France medical information market by end use, 2016 - 2027 (USD Million)
TABLE 99 France pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 100 France innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 101 France generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 102 France biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 103 France biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 104 France ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 105 France biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 106 France medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 107 France diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 108 France therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 109 Italy medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 110 Italy medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 111 Italy medical information market by company size, 2016 - 2027 (USD Million)
TABLE 112 Italy medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 113 Italy medical information market by end use, 2016 - 2027 (USD Million)
TABLE 114 Italy pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 115 Italy innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 116 Italy generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 117 Italy biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 118 Italy biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 119 Italy ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 120 Italy biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 121 Italy medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 122 Italy diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 123 Italy therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 124 Spain medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 125 Spain medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 126 Spain medical information market by company size, 2016 - 2027 (USD Million)
TABLE 127 Spain medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 128 Spain medical information market by end use, 2016 - 2027 (USD Million)
TABLE 129 Spain pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 130 Spain innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 131 Spain generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 132 Spain biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 133 Spain biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 134 Spain ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 135 Spain biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 136 Spain medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 137 Spain diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 138 Spain therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 139 Asia Pacific medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 140 Asia Pacific medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 141 Asia Pacific medical information market by company size, 2016 - 2027 (USD Million)
TABLE 142 Asia Pacific medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 143 Asia Pacific medical information market by end use, 2016 - 2027 (USD Million)
TABLE 144 Asia Pacific pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 145 Asia Pacific innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 146 Asia Pacific generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 147 Asia Pacific biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 148 Asia Pacific biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 149 Asia Pacific ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 150 Asia Pacific biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 151 Asia Pacific medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 152 Asia Pacific diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 153 Asia Pacific therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 154 Japan medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 155 Japan medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 156 Japan medical information market by company size, 2016 - 2027 (USD Million)
TABLE 157 Japan medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 158 Japan medical information market by end use, 2016 - 2027 (USD Million)
TABLE 159 Japan pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 160 Japan innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 161 Japan generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 162 Japan biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 163 Japan biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 164 Japan ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 165 Japan biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 166 Japan medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 167 Japan diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 168 Japan therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 169 China medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 170 China medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 171 China medical information market by company size, 2016 - 2027 (USD Million)
TABLE 172 China medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 173 China medical information market by end use, 2016 - 2027 (USD Million)
TABLE 174 China pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 175 China innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 176 China generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 177 China biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 178 China biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 179 China ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 180 China biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 181 China medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 182 China diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 183 China therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 184 India medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 185 India medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 186 India medical information market by company size, 2016 - 2027 (USD Million)
TABLE 187 India medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 188 India medical information market by end use, 2016 - 2027 (USD Million)
TABLE 189 India pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 190 India innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 191 India generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 192 India biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 193 India biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 194 India ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 195 India biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 196 India medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 197 India diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 198 India therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 199 Latin America medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 200 Latin America medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 201 Latin America medical information market by company size, 2016 - 2027 (USD Million)
TABLE 202 Latin America medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 203 Latin America medical information market by end use, 2016 - 2027 (USD Million)
TABLE 204 Latin America pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 205 Latin America innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 206 Latin America generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 207 Latin America biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 208 Latin America biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 209 Latin America ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 210 Latin America biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 211 Latin America medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 212 Latin America diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 213 Latin America therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 214 Brazil medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 215 Brazil medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 216 Brazil medical information market by company size, 2016 - 2027 (USD Million)
TABLE 217 Brazil medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 218 Brazil medical information market by end use, 2016 - 2027 (USD Million)
TABLE 219 Brazil pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 220 Brazil innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 221 Brazil generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 222 Brazil biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 223 Brazil biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 224 Brazil ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 225 Brazil biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 226 Brazil medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 227 Brazil diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 228 Brazil therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 229 Mexico medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 230 Mexico medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 231 Mexico medical information market by company size, 2016 - 2027 (USD Million)
TABLE 232 Mexico medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 233 Mexico medical information market by end use, 2016 - 2027 (USD Million)
TABLE 234 Mexico pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 235 Mexico innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 236 Mexico generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 237 Mexico biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 238 Mexico biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 239 Mexico ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 240 Mexico biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 241 Mexico medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 242 Mexico diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 243 Mexico therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 244 MEA medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 245 MEA medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 246 MEA medical information market by company size, 2016 - 2027 (USD Million)
TABLE 247 MEA medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 248 MEA medical information market by end use, 2016 - 2027 (USD Million)
TABLE 249 MEA pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 250 MEA innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 251 MEA generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 252 MEA biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 253 MEA biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 254 MEA ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 255 MEA biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 256 MEA medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 257 MEA diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 258 MEA therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 259 South Africa medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 260 South Africa medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 261 South Africa medical information market by company size, 2016 - 2027 (USD Million)
TABLE 262 South Africa medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 263 South Africa medical information market by end use, 2016 - 2027 (USD Million)
TABLE 264 South Africa pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 265 South Africa innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 266 South Africa generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 267 South Africa biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 268 South Africa biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 269 South Africa ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 270 South Africa biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 271 South Africa medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 272 South Africa diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 273 South Africa therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 274 KSA medical information market by service provider, 2016 - 2027 (USD Million)
TABLE 275 KSA medical information market by therapeutic area, 2016 - 2027 (USD Million)
TABLE 276 KSA medical information market by company size, 2016 - 2027 (USD Million)
TABLE 277 KSA medical information market by product life cycle, 2016 - 2027 (USD Million)
TABLE 278 KSA medical information market by end use, 2016 - 2027 (USD Million)
TABLE 279 KSA pharmaceuticals market by category, 2016 - 2027 (USD Million)
TABLE 280 KSA innovators market by product life cycle, 2016 - 2027 (USD Million)
TABLE 281 KSA generics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 282 KSA biotechnology companies’ market by category, 2016 - 2027 (USD Million)
TABLE 283 KSA biologics market by product life cycle, 2016 - 2027 (USD Million)
TABLE 284 KSA ATMPs market by product life cycle, 2016 - 2027 (USD Million)
TABLE 285 KSA biosimilars market by product life cycle, 2016 - 2027 (USD Million)
TABLE 286 KSA medical device manufacturers market by category, 2016 - 2027 (USD Million)
TABLE 287 KSA diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
TABLE 288 KSA therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews breakdown
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Medical information market snapshot, 2019 (USD Million)
Fig. 10 Medical information market dynamics
Fig. 11 Medical information market driver impact
Fig. 12 Medical information Services FTE Adoption
Fig. 13 Medical information market restraint impact
Fig. 14 Medical information process
Fig. 15 MI structure
Fig. 16 MI organization structure
Fig. 17 Estimated budget allocation of medical affairs activities at global level, 2019
Fig. 18 Activities performed by Mi call centers 2019, estimated
Fig. 19 Average % of drug safety budget contributed by function at global level
Fig. 20 Estimated company market share analysis, 2019 (%)
Fig. 21 Medical information market: Service provider movement analysis
Fig. 22 Medical information Service provider dashboard
Fig. 23 Global In-house market, 2016 - 2027 (USD Million)
Fig. 24 Global contract outsourcing market, 2016 - 2027 (USD Million)
Fig. 25 Medical information market: Therapeutic area movement analysis
Fig. 26 Medical information market therapeutic area dashboard
Fig. 27 Global oncology market, 2016 - 2027 (USD Million)
Fig. 28 Global neurology market, 2016 - 2027 (USD Million)
Fig. 29 Global cardiology market, 2016 - 2027 (USD Million)
Fig. 30 Global immunology market, 2016 - 2027 (USD Million)
Fig. 31 Global others market, 2016 - 2027 (USD Million)
Fig. 32 Medical information market: Company size movement analysis
Fig. 33 Medical information company size dashboard
Fig. 34 Global small companies’ market, 2016 - 2027 (USD Million)
Fig. 35 Global medium-sized companies market, 2016 - 2027 (USD Million)
Fig. 36 Global large scale companies market, 2016 - 2027 (USD Million)
Fig. 37 Medical information market: Product life cycle movement analysis
Fig. 38 Medical information market product life cycle dashboard
Fig. 39 Global Preclinical market, 2016 - 2027 (USD Million)
Fig. 40 Global clinical market, 2016 - 2027 (USD Million)
Fig. 41 Global PMA market, 2016 - 2027 (USD Million)
Fig. 42 Medical information market: Category movement analysis
Fig. 43 Medical information market category dashboard
Fig. 44 Global pharmaceuticals market, 2016 - 2027 (USD Million)
Fig. 45 Global innovators market, 2016 - 2027 (USD Million)
Fig. 46 Global pre-clinical market, 2016 - 2027 (USD Million)
Fig. 47 Global Clinical market, 2016 - 2027 (USD Million)
Fig. 48 Global PMA market, 2016 - 2027 (USD Million)
Fig. 49 Global Generics market, 2016 - 2027 (USD Million)
Fig. 50 Global pre-clinical market, 2016 - 2027 (USD Million)
Fig. 51 Global clinical market, 2016 - 2027 (USD Million)
Fig. 52 Global PMA market, 2016 - 2027 (USD Million)
Fig. 53 Global Biotechnology companies market, 2016 - 2027 (USD Million)
Fig. 54 Global biologics market, 2016 - 2027 (USD Million)
Fig. 55 Global pre-clinical market, 2016 - 2027 (USD Million)
Fig. 56 Global clinical market, 2016 - 2027 (USD Million)
Fig. 57 Global PMA market, 2016 - 2027 (USD Million)
Fig. 58 Global ATMPs market, 2016 - 2027 (USD Million)
Fig. 59 Global pre-clinical market, 2016 - 2027 (USD Million)
Fig. 60 Global clinical market, 2016 - 2027 (USD Million)
Fig. 61 Global PMA market, 2016 - 2027 (USD Million)
Fig. 62 Global biosimilar market, 2016 - 2027 (USD Million)
Fig. 63 Global pre-clinical market, 2016 - 2027 (USD Million)
Fig. 64 Global clinical market, 2016 - 2027 (USD Million)
Fig. 65 Global PMA market, 2016 - 2027 (USD Million)
Fig. 66 Global medical device manufacturers market, 2016 - 2027 (USD Million)
Fig. 67 Global therapeutic medical devices market, 2016 - 2027 (USD Million)
Fig. 68 Global pre-clinical market, 2016 - 2027 (USD Million)
Fig. 69 Global clinical market, 2016 - 2027 (USD Million)
Fig. 70 Global PMA market, 2016 - 2027 (USD Million)
Fig. 71 Global diagnostic medical devices market, 2016 - 2027 (USD Million)
Fig. 72 Global pre-clinical market, 2016 - 2027 (USD Million)
Fig. 73 Global clinical market, 2016 - 2027 (USD Million)
Fig. 74 Global PMA market, 2016 - 2027 (USD Million)
Fig. 75 Regional market place: Key takeaways
Fig. 76 North America medical information market share by countries, 2019
Fig. 77 Europe medical information market share by countries, 2019
Fig. 78 Asia Pacific medical information market share by countries, 2019
Fig. 79 Latin America medical information market share by countries, 2019
Fig. 80 MEA medical information market share by countries, 2019
Fig. 81 Regional outlook, 2019 & 2027
Fig. 82 North America medical information market, 2016 - 2027 (USD Million)
Fig. 83 The U.S. medical information market, 2016 - 2027 (USD Million)
Fig. 84 Canada medical information market, 2016 - 2027 (USD Million)
Fig. 85 Europe medical information market, 2016 - 2027 (USD Million)
Fig. 86 The U.K. medical information market, 2016 - 2027 (USD Million)
Fig. 87 Germany medical information market, 2016 - 2027 (USD Million)
Fig. 88 France medical information market, 2016 - 2027 (USD Million)
Fig. 89 Italy medical information market, 2016 - 2027 (USD Million)
Fig. 90 Spain medical information market, 2016 - 2027 (USD Million)
Fig. 91 Asia Pacific Medical information market, 2016 - 2027 (USD Million)
Fig. 92 Japan medical information market, 2016 - 2027 (USD Million)
Fig. 93 China medical information market, 2016 - 2027 (USD Million)
Fig. 94 India medical information market, 2016 - 2027 (USD Million)
Fig. 95 Latin America medical information market, 2016 - 2027 (USD Million)
Fig. 96 Brazil medical information market, 2016 - 2027 (USD Million)
Fig. 97 Mexico medical information market, 2016 - 2027 (USD Million)
Fig. 98 MEA medical information market, 2016 - 2027 (USD Million)
Fig. 99 South Africa medical information market, 2016 - 2027 (USD Million)
Fig. 100 Saudi Arabia medical information market, 2016 - 2027 (USD Million)
Fig. 101 Organization Structure - McKesson Corporation
Fig. 102 SWOT - McKesson Corporation
Fig. 103 Organization Structure - Parexel International Corporation
Fig. 104 SWOT - Parexel International Corporation
Fig. 105 Organization Structure - IQVIA
Fig. 106 SWOT - IQVIA
Fig. 107 Organization Structure - C3i Solutions
Fig. 108 SWOT - C3i Solutions
Fig. 109 Organization Structure - PrimeVigilance
Fig. 110 SWOT - PrimeVigilance
Fig. 111 Organization Structure - ProPharma
Fig. 112 SWOT - ProPharma
Fig. 113 Organization Structure - Accenture
Fig. 114 SWOT - Accenture
Fig. 115 Organization Structure - Cognizant
Fig. 116 SWOT - Cognizant
Fig. 117 Organization Structure - Infosys
Fig. 118 SWOT - Infosys
Fig. 119 Organization Structure - PharmCentrre
Fig. 120 SWOT - PharmCentre
Fig. 121 Vendor selection criteria
Fig. 122 Reasons for switching the service provider

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon